American International Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,219
| Closed | -$29.9K | – | 3154 |
|
|
2023
Q1 | $29.9K | Buy |
13,219
+263
| +2% | +$594 | ﹤0.01% | 2836 |
|
|
2022
Q4 | $45.2K | Sell |
12,956
-47
| -0.4% | -$164 | ﹤0.01% | 2776 |
|
|
2022
Q3 | $481K | Buy |
13,003
+184
| +1% | +$6.81K | ﹤0.01% | 1604 |
|
|
2022
Q2 | $243K | Buy |
12,819
+488
| +4% | +$9.25K | ﹤0.01% | 2065 |
|
|
2022
Q1 | $333K | Buy |
12,331
+4,012
| +48% | +$108K | ﹤0.01% | 1954 |
|
|
2021
Q4 | $187K | Sell |
8,319
-249
| -3% | -$5.6K | ﹤0.01% | 2411 |
|
|
2021
Q3 | $225K | Buy |
8,568
+161
| +2% | +$4.23K | ﹤0.01% | 2365 |
|
|
2021
Q2 | $269 | Sell |
8,407
-136
| -2% | -$4 | ﹤0.01% | 2318 |
|
|
2021
Q1 | $301 | Buy |
8,543
+22
| +0.3% | +$1 | ﹤0.01% | 2132 |
|
|
2020
Q4 | $273 | Sell |
8,521
-126
| -1% | -$4 | ﹤0.01% | 2104 |
|
|
2020
Q3 | $325K | Buy |
8,647
+48
| +0.6% | +$1.8K | ﹤0.01% | 1830 |
|
|
2020
Q2 | $385K | Buy |
+8,599
| New | +$385K | ﹤0.01% | 1728 |
|